In the six decades of Cuban medical collaboration abroad, its health personnel have assisted 1.988 billion people in the world, almost a third of mankind, said Dr. Jorge Delgado Bustillo, director of the Central Unit for Medical Cooperation (UCCM).

The CIGB-258, a peptide designed to reduce inflammatory processes, and the monoclonal antibody Itolizumab (Anti-CD6) have shown great effectiveness for the survival of critical and severe COVID-19 patients in Cuba, announced Friday Francisco Duran, national director of epidemiology at the ministry of public health.